242 episodes

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts - from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases.

Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion.

If you enjoy the podcast, please leave us a rating and review!

For more news visit www.vjhemonc.com

VJHemOnc Podcast VJHemOnc

    • Health & Fitness
    • 4.5 • 2 Ratings

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts - from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases.

Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion.

If you enjoy the podcast, please leave us a rating and review!

For more news visit www.vjhemonc.com

    Treating LR-MDS beyond ESA failure: currently approved agents, novel approaches & future outlooks

    Treating LR-MDS beyond ESA failure: currently approved agents, novel approaches & future outlooks

    While there have been advances in the treatment of lower-risk myelodysplastic syndromes (LR-MDS) in recent years, one major challenge that...

    • 46 min
    BPDCN treatment and management: CD123-targeting agents, CNS involvement & approaching pediatric/AYA patients

    BPDCN treatment and management: CD123-targeting agents, CNS involvement & approaching pediatric/AYA patients

    Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy originating from plasmacytoid dendritic cells, characterized by skin lesions...

    • 34 min
    The future of CAR-T therapy in lymphoma, addressing the risk of secondary malignancy & the optimal sequencing of these agents with bispecific antibodies

    The future of CAR-T therapy in lymphoma, addressing the risk of secondary malignancy & the optimal sequencing of these agents with bispecific antibodies

    Immunotherapeutic approaches, including CAR T-cells and bispecific antibodies, have become well-established in later lines of non-Hodgkin lymphoma (NHL) treatment. CAR...

    • 12 min
    iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials

    iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials

    The 17th International Workshop on Multiple Myeloma (iwMyeloma 2024) was held recently in Miami, FL, and brought together experts from...

    • 27 min
    Managing anemia in MF, key emerging trials in the UK, and approaching young patients with MPNs

    Managing anemia in MF, key emerging trials in the UK, and approaching young patients with MPNs

    Myelofibrosis (MF) is a hematologic malignancy that causes progressive bone marrow fibrosis and presents with other clinical manifestations, including anemia...

    • 11 min
    Highlights from EBMT 2024: treating & managing GvHD & understanding the role of the gut microbiome

    Highlights from EBMT 2024: treating & managing GvHD & understanding the role of the gut microbiome

    Graft-versus-host disease (GvHD) is a common complication following allogeneic stem cell transplantation (alloSCT), which is typically classified as acute or...

    • 22 min

Customer Reviews

4.5 out of 5
2 Ratings

2 Ratings

Top Podcasts In Health & Fitness

Huberman Lab
Scicomm Media
Nothing much happens: bedtime stories to help you sleep
iHeartPodcasts
Perform with Dr. Andy Galpin
Scicomm Media
On Purpose with Jay Shetty
iHeartPodcasts
Passion Struck with John R. Miles
John R. Miles
The Dr. John Delony Show
Ramsey Network

You Might Also Like

Blood Cancer Talks
Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
Plenary Session
Vinay Prasad, MD MPH
Two Onc Docs
Sam and Karine
Hematologic Oncology Update
Dr Neil Love
Blood Podcast
American Society of Hematology
WolverHeme Happy Hour
Bernard Marini, Anthony Perissinotti, et al.